Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Bloomberg Customers

February 09, 2016 7:52 AM ET

Healthcare Providers and Services

Company Overview of ARUP Laboratories, Inc.

Company Overview

ARUP Laboratories, Inc. operates a clinical and anatomic pathology reference laboratory in the United States. It offers ATOP, a laboratory analytics service to identify over-, under-, and mis-utilization of individual laboratory tests; ARUP Connect, an online information system for referral test management that enables to access test results, submit statistical data, and retrieve files; and ARUP Consult, a guide on PDA and Web platforms to assist the clinician with laboratory test selection and interpretation. The company also provides ARUP Direct, a start-to-finish outreach program to help clients; ARUP Gateway, an integrated customer test menu tool to serve the client's outreach medical co...

500 Chipeta Way

Salt Lake City, UT 84108-1221

United States

Founded in 1984





Key Executives for ARUP Laboratories, Inc.

Chief Executive Officer and President
Chief Operating Officer and Executive Vice President of Corporate Communications
Senior Technical Vice President, Medical Director of Immunology & Infectious Disease Laboratory and Executive Director
Administrative Vice President and Medical Director of Animal Reference Pathology Laboratory
Senior Vice President and Director of Marketing
Compensation as of Fiscal Year 2015.

ARUP Laboratories, Inc. Key Developments

ARUP Laboratories and the Children's Hospital of Philadelphia Form Partnership to Offer High-Resolution HLA Genotyping by Next Generation Sequencing

ARUP Laboratories announced that they will be offering high-resolution HLA genotyping by next generation sequencing (NGS) under an agreement with The Children's Hospital of Philadelphia (CHOP). HLA genotyping is used for identifying the best recipient/donor match combination prior to hematopoietic stem cell transplantation (HSCT). HLA genes are the most polymorphic gene family found in the entire human genome, with more than 10,000 different HLA alleles reported so far. Currently, the standard of care for HLA genotyping to select a donor for HSCT is to use a low/intermediate resolution SSO/SSP test first and then reflex the candidates to confirmatory Sanger Sequence Based Typing (SBT) to obtain higher resolution allele information to finalize the matched donor. Sanger SBT produces incomplete and ambiguous results by analyzing only sections of the HLA genes and failing to distinguish among different alleles due to difficulty with resolving cis/trans chromosomal positions of those alleles. NGS is able to overcome the limitations of Sanger SBT by performing large number of long clonal sequencing reactions, allowing reporting of complete and unambiguous HLA genotyping results.

ARUP Laboratories Adds Prosigna to its Test Menu

ARUP Laboratories announced on March 3, that it has added the Prosigna Breast Cancer Prognostic Gene Signature assay to its comprehensive suite of breast cancer diagnostic tests. This assay is FDA 510(k) cleared for node-negative (stage I or II) or node-positive (stage II), hormone receptor-positive (HR+) breast cancer patients. Prosigna provides an individualized assessment of a patient's risk of recurrence at ten years given endocrine therapy alone. The test uses the biology of the tumor and clinical variables to assess risk and has shown improved prognostic accuracy over other breast cancer tests on the market. The University of Utah and the Huntsman Cancer Institute in Salt Lake City were integral in developing the 50-gene expression signature. Dr. Philip Bernard, a co-inventor of the test and medical director of molecular oncology diagnostics at ARUP Laboratories, oversees the test and can provide additional consultation through ARUP Client Services.

Similar Private Companies By Industry

Company Name Region
Premiere Radiation Oncology United States
AWPRx , LLC United States
Mccall Memorial Hospital District United States
REM Health of Wisconsin, Inc. United States
Medcor, Inc. United States

Recent Private Companies Transactions

Private Placement
January 7, 2016
PierianDx, Inc.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact ARUP Laboratories, Inc., please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at